Our platform recently supported a major pharmaceutical company in optimizing their trial completion process through collaborative patient exit survey development.
Principal investigators used our discussion tools to review and refine survey questions, ensuring they would effectively capture crucial data about patient recruitment channels and motivations, clinical team communication quality, physical and mental treatment benefits and satisfaction with dosing schedules and procedures.
By involving investigators in survey development, sites took greater ownership of the feedback process, leading to higher completion rates and more valuable insights for future trials. This collaborative approach demonstrated how sustained engagement throughout the trial translates into better outcomes for both sponsors and sites.